TBPH Long-Term Debt
Theravance Biopharma Inc · Long-Term Debt
TBPH Long-Term Debt
Latest reported$64.55Mperiod ending
TBPH FY Long-Term Debt ($0.00 → $64.55M)
Annual long-term debt
High-resolution chart · PNG
TBPH long-term debt history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Long-Term Debt (USD) |
|---|---|
| 64,553,000 | |
| 39,108,000 | |
| 45,236,000 | |
| 45,407,000 | |
| 652,075,000 | |
| 647,056,000 | |
| 492,915,000 | |
| 454,353,000 | |
| 223,746,000 | |
| 222,676,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |